75 FR 107 pgs. 31795-31796 - Office of Biotechnology Activities; Recombinant DNA Research: Amended Notice of Meeting
Type: NOTICEVolume: 75Number: 107Pages: 31795 - 31796
FR document: [FR Doc. 2010-13484 Filed 6-3-10; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: National Institutes of Health
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of Biotechnology Activities; Recombinant DNA Research: Amended Notice of Meeting
ACTION:
Notice of cancellation of consideration of a proposed action under Section III-A-1 of the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines).
SUMMARY:
Notice of a discussion of a proposed action under Section III-A-1 published on May 24, 2010 (75 FR 28811) is withdrawn. The discussion that was to be held at the June 16-17, 2010 meeting of the NIH Recombinant DNA Advisory Committee has been deferred at the request of the principal investigator.
FOR FURTHER INFORMATION CONTACT:
OBA by e-mail at oba@od.nih.gov, or telephone at 301-496-9838, if you have questions, or require additional information.
Dated: May 26, 2010.
Jacqueline Corrigan-Curay,
Acting Director, Office of Biotechnology Activities, National Institutes of Health.
[FR Doc. 2010-13484 Filed 6-3-10; 8:45 am]
BILLING CODE 4140-01-P